A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

Summary

The objective of this study is to confirm efficacy of ASP1941 based on the changes in HbA1c and to assess its safety in subjects with type 1 diabetes mellitus receiving ASP1941 once daily in combination with insulin for 24 weeks. This study will also assess the safety/efficacy of long-term treatment (52 weeks).

Timeline

Start

2016-08-29

Primary completion

2017-07-22

Completion

2018-03-15

Drugs

Indications